Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04827914 · ClinicalTrials.gov registry record · NA
Evaluation of an "Opt-Out" Inpatient Smoking Cessation Service on Smoking Behavior Study #1
A NA study of Smoking Cessation, sponsored by Medical University of South Carolina.
- Active
- Registry status
- NA
- Development phase
- 1,122
- Enrollment target
- 6
- Study locations
NCT04827914: Active NA study of Smoking Cessation, sponsored by Medical University of South Carolina.
NCT04827914 is a NA study of Smoking Cessation that is active but no longer recruiting, run by Medical University of South Carolina. The registered enrollment target is 1,122 participants, above the 469-participant average among 188 other Smoking Cessation trials with a reported enrollment target (139% higher). The trial reports 6 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04827914, a NA study of Smoking Cessation, is active but no longer recruiting, sponsored by Medical University of South Carolina.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,122 participants
- Enrollment target
- 6
- Study locations
Study Summary
The modest goal of this study is to replicate the behavioral outcomes of the opt out MUSC-Tobacco Treatment Program in the following three patient groups: 1) psychiatric inpatients housed in the Institute of Psychiatry (IOP) in Charleston; 2) non-IOP patients seen in Charleston; and 3) patients seen in the other four MUSC affiliated hospitals combined (i.e., Chester, Florence, Lancaster, and Marion). The aims and the design/methods utilized for evaluation will be the same for each of the three patient groups.
Primary Outcome
Hypothesize that patients exposed to the enhanced care intervention compared to basic care will report a 2-fold higher 7-day non-smoker prevalence rate after hospitalization (i.e., 20% vs 10%)
Conditions Studied
Interventions
- BEHAVIORAL Enhanced Care
- BEHAVIORAL Basic Care
Study Locations (6)
South Carolina
- Institute of Psychiatry - Charleston
- MUSC - Charleston
- MUSC - Chester
- MUSC - Florence
- MUSC - Lancaster
- MUSC - Marion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,122 participants |
| Start Date | 2021-03-08 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
What the registry record for NCT04827914 still lists
NCT04827914 is an interventional study that assigns participants to a tested intervention. Its 1,122 participants enrollment target places it among the larger protocols in the corpus, above the 469-participant average among 188 other Smoking Cessation trials with a reported enrollment target (139% higher).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Care is the first listed.
NCT04827914 lists 6 locations in 1 state (South Carolina).
Frequently Asked Questions
What is clinical trial NCT04827914 about?
NCT04827914 is a clinical study titled "Evaluation of an "Opt-Out" Inpatient Smoking Cessation Service on Smoking Behavior Study #1". The modest goal of this study is to replicate the behavioral outcomes of the opt out MUSC-Tobacco Treatment Program in the following three patient groups: 1) psychiatric inpatients housed in the Institute of Psychiatry (IOP) in Charleston; 2) non-IOP patients seen in Charleston; and 3) patients seen...
What is the current status of trial NCT04827914?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,122 participants. The study started on 2021-03-08. Estimated completion is 2026-09-01.
What conditions does trial NCT04827914 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT04827914?
The interventions under investigation include: Enhanced Care (BEHAVIORAL), Basic Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT04827914?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04827914 being conducted?
This trial has 6 study locations across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04827914's enrollment target sits among peer trials
1,122 20th of 188 higher than 169 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05691478 · 1,122 participants · Phase 2
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
- NCT05438329 · 1,123 participants · Phase 1
First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors
- NCT06952504 · 1,123 participants · Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- NCT02140255 · 1,120 participants · Phase 1
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI